Literature DB >> 11498509

Identification of the dopamine autoreceptor in the guinea-pig retina as D(2) receptor using novel subtype-selective antagonists.

B Weber1, E Schlicker, P Sokoloff, H Stark.   

Abstract

1. Dopamine release in the retina is subject to modulation via autoreceptors, which belong to the D(2) receptor family (encompassing the D(2), D(3) and D(4) receptors). The aim of the present study was to determine the receptor subtype (D(2) vs D(3)) involved in the inhibition of dopamine release in guinea-pig retinal discs, using established (haloperidol, (S)-nafadotride) and novel dopamine receptor antagonists (ST-148, ST-198). 2. hD(2L) and hD(3) receptors were expressed in CHO cells and the pK(i) values determined in binding studies with [(125)I]-iodosulpride were: haloperidol 9.22 vs 8.54; ST-148 7.85 vs 6.60; (S)-nafadotride 8.52 vs 9.51; ST-198 6.14 vs 7.92. 3. The electrically evoked tritium overflow from retinal discs preincubated with [(3)H]-noradrenaline (which represents quasi-physiological dopamine release) was inhibited by the dopamine receptor agonists B-HT 920 (talipexole) and quinpirole (maximally by 82 and 71%; pEC(50) 5.80 and 5.83). The concentration-response curves of these agonists were shifted to the right by haloperidol (apparent pA(2) 8.69 and 8.23) and ST-148 (7.52 and 7.66). (S)-Nafadotride 0.01 microM and ST-198 0.32 microM did not affect the concentration-response curve of B-HT 920. 4. The dopamine autoreceptor in the guinea-pig retina can be classified as a D(2) receptor. ST-148 and ST-198 show an improved selectivity for D(2) and D(3) receptors when compared to haloperidol and (S)-nafadotride, respectively.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498509      PMCID: PMC1621144          DOI: 10.1038/sj.bjp.0704192

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

Review 1.  Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects.

Authors:  P G Strange
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

2.  Immunocytological localization of dopamine in the guinea pig retina.

Authors:  S J Oh; I B Kim; E J Lee; K Y Kim; H I Kim; M H Chun
Journal:  Cell Tissue Res       Date:  1999-12       Impact factor: 5.249

3.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

4.  The evolution of retinal vascularization in mammals. A comparison of vascular and avascular retinae.

Authors:  J Chase
Journal:  Ophthalmology       Date:  1982-12       Impact factor: 12.079

5.  Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor.

Authors:  M D Wood; I Boyfield; D J Nash; F R Jewitt; K Y Avenell; G J Riley
Journal:  Eur J Pharmacol       Date:  2000-10-27       Impact factor: 4.432

6.  Dopamine and 7-OH-DPAT may act on D(3) receptors to inhibit tuberoinfundibular dopaminergic neurons.

Authors:  J Y Lin; S H Yen; K R Shieh; S L Liang; J T Pan
Journal:  Brain Res Bull       Date:  2000-08       Impact factor: 4.077

Review 7.  Catecholamine systems in the brain of vertebrates: new perspectives through a comparative approach.

Authors:  W J Smeets; A González
Journal:  Brain Res Brain Res Rev       Date:  2000-09

8.  Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor.

Authors:  M L Dubocovich; M I Masana; S Iacob; D M Sauri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-03       Impact factor: 3.000

9.  Pharmacological differences between the D-2 autoreceptor and the D-1 dopamine receptor in rabbit retina.

Authors:  M L Dubocovich; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

10.  Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs.

Authors:  E Schlicker; W Schunack; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

View more
  5 in total

1.  Dopamine D2 receptors preferentially regulate the development of light responses of the inner retina.

Authors:  Ning Tian; Hong-ping Xu; Ping Wang
Journal:  Eur J Neurosci       Date:  2014-11-13       Impact factor: 3.386

2.  High-throughput respirometric assay identifies predictive toxicophore of mitochondrial injury.

Authors:  Lauren P Wills; Gyda C Beeson; Richard E Trager; Christopher C Lindsey; Craig C Beeson; Yuri K Peterson; Rick G Schnellmann
Journal:  Toxicol Appl Pharmacol       Date:  2013-06-26       Impact factor: 4.219

3.  Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs.

Authors:  Feng Dong; Zhina Zhi; Miaozhen Pan; Ruozhong Xie; Xiaoyi Qin; Runxia Lu; Xinjie Mao; Jiang-Fan Chen; Mark D P Willcox; Jia Qu; Xiangtian Zhou
Journal:  Mol Vis       Date:  2011-10-31       Impact factor: 2.367

4.  Effects of Dopamine D2-Like Receptor Antagonists on Light Responses of Ganglion Cells in Wild-Type and P23H Rat Retinas.

Authors:  Ralph Jensen
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

Review 5.  Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development.

Authors:  Bernard Le Foll; Alan A Wilson; Ariel Graff; Isabelle Boileau; Patricia Di Ciano
Journal:  Front Pharmacol       Date:  2014-07-10       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.